Startseite

Publikationen von ÖGP-Mitgliedern (ab 2008)

Pirker R;
„EGFR-directed monoclonal antibodies in non-small cell lung cancer.”
Targeted Oncology Jänner 2013 (prepublished online 9.Jänner 2013)

Pirker R, Pirolli M, Quigley J, Hulnick S, Legg J, Collins H, Vansteenkiste J;
„Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent.”
Supportive Care in Cancer Oktiber 2012 (prepublished online 25.Oktober 2012)

Petrovic M, Reiter M, Zipko H, Pohl W, Wanke T;
„Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD.”
International Journal of Chronical Obstructiv Pulmonary Dissease November 2012 (prepublished online 30.November 2012)

Kovacs G, Olschewski H;
„Pulmonary hypertension“
Deutsche Medizinsiche Wochenschrift. Oktober 2012; 137(40):2026-8

Valipour A, Kramer MR, Stanzel F, Kempa A, Asadi S, Fruchter O, Eberhardt R, Herth FJ, Ingenito EP;
„Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema.”
Frontier in Physiology Oktober 2012 (prepublished online 1.Oktober 2012)

Kovacs G, Olschewski H;
„Pulmonary hypertension“
Deutsche Medizinsiche Wochenschrift. Oktober 2012; 137(40):2026-8

Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, Schmutz R, Metnitz P;
 „Prevalence and Prognosis of Chronic Obstructive Pulmonary Disease in Critically Ill Patients between 1998 and 2008“
European Respiratory Journal September 2012 (prepublished online 27.September 2012)

Valipour A;
"Gender-related Differences in the Obstructive Sleep Apnea Syndrome."
Pneumologie September 2012 (prepublished online 17.September 2012)

Schenk P, Warszawska J, Fuhrmann V, König F, Madl C, Ratheiser K;
„Health-related quality of life of long-term survivors of intensive care: changes after intensive care treatment : Experience of an Austrian intensive care unit.“
Wiener Klinische Wochenschrift September 2012;124(17-18):624-632

Soriano JB, Lamprecht B;
„Chronic obstructive pulmonary disease: a worldwide problem.“
The Medical Clinics of North America Juli 2012;96(4):671-80

Klug G, Zwick RH, Mayr A, Schocke MF, Steinboeck P, Jaschke W, Pachinger O, Metzler B;
„Correlation of cardiovascular risk scores with myocardial high-energy phosphate metabolism”
International Journal of Cardiology Juli 2012;150(2):208-10

Lamprecht B, Porsch P, Wegleitner B, Strasser G, Kaiser B, Studnicka M;
„Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield.“
Respiratory Medicine Mai 2012;106(5):710-5.

Seyfried U, Firlinger I, Reiter M, Katz-Papatheophilou E, Koller H, Burghuber OC, Valipour A;
„A leak in the lung: endobronchial one-way valve placement as treatment for a persistent bronchopleural fistula.“
Pneumologie März 2012; 66(3):188-91

Fazekas AS, Wewalka M, Zauner C, Funk GC;
„Carboxyhemoglobin levels in medical intensive care patients: a retrospective, observational study.“
Critical Care medicine Jänner 2012;16(1):R6.

Ghofrani HA, Distler O, Gerhardt F, Gorenflo M, Grünig E, Haefeli WE, Held M, Hoeper MM, Kähler CM, Kaemmerer H, Klose H, Köllner V, Kopp B, Mebus S, Meyer A, Miera O, Pittrow D, Riemekasten G, Rosenkranz S, Schranz D, Voswinckel R, Olschewski H;
„Treatment of pulmonary arterial hypertension (PAH): Updated Recommendations of the Cologne Consensus Conference 2011“
International Journal of Cardiology Dezember 2011;154 Suppl 1:S20-33

Valipour A, Burghuber OC;
„Hypoxemia and cardiovascular disease in COPD. Not related to sleep disordered breathing after all.”
Sleep Medicine Dezember 2011 (prepublished online 1.Dezember 2011)

Kovacs G, Maier R, Aberer E, Brodmann M, Graninger W, Kqiku X, Scheidl S, Tröster N, Hesse C, Rubin L, Olschewski H;
„Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary pressures.”
Arthritis and Rheumatism November 2011 (prepublished online 29.November 2011)

Bodmann B, Havranek V, Kneussl M, Czernin J, Knoll P, Mirzaei S;
„Unexpected only pulmonary manifestation of sarcoidosis.“
Nuklearmedizin 2011;50(6):N64-5.

Pirker R, Pereira JR, von Pawel J, Krzakowski M, Ramlau R, Park K, de Marinis F, Eberhardt WE, Paz-Ares L, Störkel S, Schumacher KM, von Heydebreck A, Celik I, O'Byrne KJ;
„EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.“
Lancet Oncology November 2011 (prepublished online 3.November 2011)

Pirker R, Filipits M;
„Monoclonal antibodies against EGFR in non-small cell lung cancer.“
Critical Reviews in Oncology/Hematology Oktober 2011; 80(1):1-9.

Watzka SB, Posch F, Hochmair MJ, Setinek U, Köstler WJ, Müller MR;
„Resistance to EGFR targeting therapies in lung cancer“
Minerva Chirurgica Oktober 2011; 66(5):483-94

Wohlkoenig C, Leithner K, Deutsch A, Hrzenjak A Olschewski A, Olschewski H;
„Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.”
Cancer Letters September 2011; 308(2):134-43

Li Y, Connolly M, Nagaraj C, Tang B, Bálint Z, Popper H, Smolle-Juettner FM, Lindenmann J, Kwapiszewska G, Aaronson PI, Wohlkoenig C, Leithner K, Olschewski H, Olschewski A;
„PPAR{beta}/{delta}, the Acute Signaling Factor in Prostacyclin-Induced Pulmonary Vasodilation.”
American Journal of Respiratory Cell and Molecular Biology Oktober 2011 (prepublished online 20.Oktober 2011)

Pirker R;
„Chemotherapy: Advanced NSCLC-should we use doublets in elderly patients?“
Nature Reviews Clinical Oncology September 2011 (prepublished online 27.September 2011)

Kovacs G, Olschewski A, Berghold A, Olschewski H;
„Pulmonary vascular resistances during exercise in normal subjects-a systematic review.“
European Respiratory Journal September 2011 (prepublished 1.September).

Filipits M, Pirker R;
„Predictive markers in the adjuvant therapy of non-small cell lung cancer.“
Lung Cancer August 2011 (prepublished 30.August 2011)


Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schöniger-Hekele M, Madl C, Schenk P;
„Impact of  hypoxic hepatitis on mortality in the intensive care unit”
Intensive Care Medicine August 2011; 37(8):1302-10.

O'Byrne KJ, Gatzemeier U, Bondarenko I, Barrios C, Eschbach C, Martens UM, Hotko Y, Kortsik C, Paz-Ares L, Pereira JR, von Pawel J, Ramlau R, Roh JK, Yu CT, Stroh C, Celik I, Schueler A, Pirker R;
„Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.“
The Lancet Oncology August 2011;12(8):795-805

Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, Allison MJ, Studnicka M;
„Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease.“
Respiration August 2011; 81(6):476-82

Scheidl SJ, Englisch C, Kovacs G, Reichenberger F, Schulz R, Breithecker A, Ghofrani HA, Seeger W, Olschewski H;
„Diagnosis of CTEPH vs. IPAH using capillary to end-tidal CO2 gradients.“
European Respiratory Journal Juli 2011 (prepublished 7.Juli 2011)

Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schöniger-Hekele M, Madl C, Schenk P;
„Impact of hypoxic hepatitis on mortality in the intensive care unit.“
Intensive Care Medicine Juni 2011; 37:1302–1310

Lamprecht B, Hutarew G, Porsch P, Wegleitner B, Studnicka M;
„Successful bronchoscopic cryorecanalization in a case of endobronchial lipoma.“
Diagnostic and Therapeutic Endoscopy Juni 2011 (prepublished 6.Juni 2011)

Klug G, Zwick RH, Mayr A, Schocke MF, Steinboeck P, Jaschke W, Pachinger O, Metzler B;
„Correlation of cardiovascular risk scores with myocardial high-energy phosphate metabolism.”
International Journal of Cardiology Juni 2011; (prepublished online 6.Juni 2011)

Popper H, Wrba F, Gruber-Mösenbacher U, Hulla W, Pirker R, Hilbe W, Studnicka M, Mohn-Staudner A, Ploner F; die Arbeitsgruppe Pulmopathologie der ÖGP-IAP
„Histology-based algorithm in the molecular diagnosis of mutations of the Epidernal Growth Factor Receptor (EGFR) in non-small cell lung cancer."
Wiener Klinische Wochenschrift Mai 2011; 123(9-10):316-321

Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC;
„Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease.”
Sleep Medicine April 2011;12(4):367-72

Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA ;
„COPD in Never-Smokers: Results from the population-based BOLD Study.“
Chest April 2011; 139(4):752-63

Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC;
„Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease.”
Sleep Medicine April 2011;12(4):367-72

Veres J, Slavei K, Errhalt P, Seyt M, Ihra G;
„The Veres adapter: clinical experience with a new device for jet ventilation via a laryngeal mask airway during flexible bronchoscopy.”
Anesthesia and Analgesia März 2011; 112(3):597-600

Lamprecht B, Schirnhofer L, Kaiser B, Buist SA , Mannino DM, Studnicka M;
„Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of CO PD.”
Pulmonary Medicine Februar 2011; (prepublished online 6.Februar 2011)

Funk GC, Breyer MK, Burghuber OC, Kink E, Kirchheiner K, Kohansal R, Schmidt I, Hartl S;
„Long-term non-invasive ventilation in CO PD after acute-on-chronic respiratory failure.“
Respiratory Medicine November 2010 (prepublished online 24.November 2010)

Pirker R, Filipits M;
„Monoclonal antibodies against EGFR in nonsmall cell lung cancer.“
Critical Reviews in Oncology/Hematology November. 2010 (prepublished online 23.November 2010)

Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R; European EGFR Workshop Group.
„Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.“
Journal of Thoracic Oncology Oktober 2010; 5(10):1706-13

Berger T, Zwick RH , Stuehlinger M, Dichtl W, Poelzl G, Edlinger M, Pachinger O, Hintringer F;
„Impact of oxygen uptake efficiency slope as a marker of cardiorespiratory reserve on response to cardiac resynchronization therapy.“
Clinical Research in Cardiology September 2010 (prepublished online 27.September 2010)

Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, Allison MJ, Studnicka M.
„Using Targeted Spirometry to Reduce Non-Diagnosed Chronic Obstructive Pulmonary Disease.“
Respiration August 2010 (prepublished online 19. August 2010)

Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, Burghuber OC, Hartl S.
„Nordic Walking improves daily physical activities in CO PD: a randomised controlled trial.“
Respiratory Research August 2010; 11:112

Pirker R;
„Bevacizumab in lung cancer: hurdles in clinical development.“
The Lancet Oncology August 2010 Aug;11(8):703-4

Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Troester N, Salmhofer W, Stauber R, Fürst F, Thonhofer R, Ofner-Kopeinig P, Gruenig E, Olschewski H;
„Assessment of Pulmonary Arterial Pressure during Exercise in Collagen Vascular Disease: Echocardiography versus Right Heart Catheterisation.“
Chest August 2010; 138(2): 270-8

Huber F, Schmid-Scherzer K, Wantke F, Frantal S, Kneussl M;
„Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-internationalregistry database.“
Wiener Klinische Wochenschrift Juli 2010 (prepublished inline 14. Juli 2010)

Pirker R, Berzinec P, Brincat S, Kasan P, Ostoros G, Pesek M, Plate S, Purkalne G, Rooneem R, Skˇriˇcková J, Stanculeanu D, Timcheva C, Tzekova V, Zakotnik B, Zielinski CC, Zwitter M;
„Therapy of small cell lung cancer with emphasis on oral topotecan.“
Lung Cancer Juni 2010 (prepublished online 22.Juni 2010)

Scheidl S, Taghavi S, Reiter U, Tröster N, Kovacs G, Rienmüller R, Lang S, Klepetko W, Olschewski H;
„Intimal sarcoma of the pulmonary valve“
The Annals of Thoracic Surgery April 2010, 89(4):e25-7

Burian B, Storka A, Marzluf BA, Yen YC, Lambers C, Robibaro B, Vonbank K, Mosgoeller W, Petkov V;
„Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients“
Peptides April 2010, 31(4):603-8

Olschewski H, Hoeper MM , Behr J, Ewert R, Meyer A, Borst MM , Winkler J, Pfeifer M, Wilkens H, Ghofrani HA, Nikkho S, Seeger W;
„Long-term therapy with inhaled iloprost in patients with pulmonary hypertension“
Respiratory Medicine Februar 2010 (prepublished online 10. Februar 2010)

Spiro SG , Tanner NT , Silvestri GA, Janes SM , Lim E, Vansteenkiste JF, Pirker R;
„Lung cancer: Progress in diagnosis, staging and therapy“
Respirology Jänner 2010, 15(1):44-50

Schlick W, Pohl W, Pfeiffer KP, Aigner K, Forche G, Kneussl M, Zwick H;
„Evaluation of 3-5 months add-on therapy with montelukast in patients with non-controlled asthma in Austria: the ST AR open-label, real-world, observational study.”
Current Medical Research and Opinion Jänner 2010 (prepublished online 6.Jänner 2010)

Bush A, Zach M;
„Medicines for children in Europe: from proposals to practicalities”
European Respiratory Journal Jänner 2010; 35(1):228-9

Robibaro B, Kropfmueller A, Prokop M, Haber P, Gisslinger H;
„Imatinib, cytokines and interstitial lung disease in a patient with primary myelofibrosis“
Annals of Hematology Dezember 2009 (prepublished online 19.Dezember 2009)

Pirker R, Minar W;
„Chemotherapy of Advanced Non-Small Cell Lung Cancer”
Frontiers of Radiation Therapy and Oncology November 2010; 42:157-163. (prepublished online 24 .November 2009)

Stauber RE, Olschewski H;
„Portopulmonary hypertension: short review.”
European Journal of Gastroenterology and Hepatology
November 2009 (prepublished online 10 .November 2009)

Funk GC , Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG;
„Incidence and prognosis of dysnatremias present on ICU admission” Intensive Care Medicine Oktober 2009; (prepublished 22.Oktober 2009)

Prosch H, Oschatz E, Eisenhuber E, Gahleitner S, Hochmair M, Mashaal S, Mostbeck GH;
„Sonographie der Leber nach CT-Staging von Patienten mit Bronchialkarzinom: eine retrospektive Analyse“
Ultraschall in Medizin Oktober 09; 30:551-557 (prepublished online 6.Oktober 09)

Steinacher I, Lamprecht B, Lobendanz M, Zoller H, Dartevelle P, Fadel E, Studnicka M;
„Successful surgical treatment of thoracic multiorgan lymphangiomatosis.”
Wiener Klinische Wochenschrift Oktober 2009; 121(19-20):644-647

Watzka SB, Setinek U, Prosch H, Mueller MR;
“Primary synovial sarcoma of the lung as an incidental finding”
Interactive Cardiovascular Thoracic Surgery September 2009 (prepublished online 22. September 2009)

Burghuber OC, Valipour A;
„Knowing chronic obstructive pulmonary disease by heart: cumulating evidence of systemic vascular dysfunction.“
American Journal of Respiratory Critical Care Medicine September 2009; 180(6):513-20

Klein M, Gauggel S, Sachs G, Pohl W;
„Impact of chronic obstructive pulmonary disease (COPD) on attention functions.“
Respiratory Medicine September 2009 (prepublished online 10.September 2009)

Pirker R;
„Erythropoiesis-stimulating agents in patients with cancer: update on safety issues”
Expert Opinon on Drug Safty September 2009; 8(5):515-22

Scheidl S, Kovacs G, Stacher E, Popper H, Olschewski H;
„A 55-year-old craftsman with dyspnea and clubbing: a case report“
Cases Journal September 2009; 2:8579

Prosch H, Oschatz E, Eisenhuber E, Wohlschlager H, Mostbeck
GH;
„CT fluoroscopy guided transpleural cutting needle biopsy of small (</=2,5 cm) subpleural pulmonary nodules“
European Journal of Radiology August 2009 (prepublished online 24.August 2009)

Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Tröster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H;
“Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma”
American Journal of Respiratory Critical Care Medicine August 2009 (prepublished online 13.August 2009)

Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C;
„Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients.”
Intensive Care Med August 2009; 35(8):1397-405

Oschatz E, Prosch H, Kohansal R, Valipour A, Mostbeck G;
„CO PD and osteoporosis: detection and grading of vertebral fracture on lateral chest radiography“
Journal of Thoracic Imaging August 2009; 24(3):212-5

Wantke F, Kneussl M, Hubner M, Derfler K, Brücke T, Schmaldienst
S;
„Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (CO P)“
Rheumatology International Juli 2009 (prepublished online 29.Juli 2009)

Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M;
„EGFR/KRA S/BRAF mutations in primary lung adenocarcinomas
and corresponding locoregional lymph node metastases”
Clincal Cancer Research Juli 2009 (prepublished 7.Juli 2009)

Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D‘Assie A, Valentin A, Hartl S;
„Incidence and outcome of weaning from mechanical ventilation according to new categories“
European Respiratory Joural Juli 2009 (prepublished online 1.Juli 2009)

Stacher E, Gruber-Mösenbacher U, Halbwedl I, Paolo Dei Tos A, Cavazza A, Papotti M, Carvalho L, Huber M, Ermert L, Popper H;
„The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: New potential therapeutic targets?”
Lung Cancer Juli 2009; 65(1):49-55

Zwick RH, Burghuber OC, Dovjak N, Hartl S, Kössler W,
Lichtenschopf A, Müller R, Zwick H;
„The effect of one year outpatient pulmonary rehabilitation on patients with CO PD”
Wiener Klinische Wochenschrift Juni 2009; 121(5-6):189-95

Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski  M, Ramlau R, Vynnychenko I, Park K, Yu CT , Ganul  V, Roh JK, Bajetta E, O‘Byrne K, de Marinis F, Eberhardt   W, Goddemeier T, Emig M, Gatzemeier U;
„Cetuximab plus chemotherapy in patients with advanced   non-small-cell lung cancer (FLE X): an open-label  randomised phase III trial“
Lancet Mai 2009; 373(9674):1525-31

Robibaro B, Funk GC, Dekan G, Demetriou D, Ziesche R, Winkler S, Block LH;
„Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania“
European Respiratory Journal Mai 2009, 33(5):1216-9

Cekici L, Valipour A, Kohansal R, Burghuber OC;
„Short-term effects of inhaled salbutamol on autonomic   cardiovascular control in healthy subjects: a placebocontrolled  study“
British Journal of Clinical Pharmacology April 2009;   67(4):394-402

Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB.
„The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort.“
American Journal of Respiratory and Critical Care Medicin (prepublished 2.April 2009)

Lambers C, Hacker S, Posch M, Hoetzenecker K, Pollreisz A, Lichtenauer M, Klepetko W, Ankersmit HJ;
„T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease“
Clinial and Expirmental Immunology März 2009, 155(3):466-75

Gappa M, Paton J, Baraldi E, Bush A, Carlsen KH, de Jongste JC, Eber E, Fauroux B, McKenzie S, Noël JL,   Palange P, Pohunek P, Priftis K, Séverin T, Wildhaber  JH, Zivkovic Z, Zach M;
„Paediatric HERME S: update of the European Training Syllabus for Paediatric Respiratory Medicine”
European Respiratory Journal März 2009; 33: 464-465

Kovacs G, Berghold A, Scheidl S, Olschewski H;
„Pulmonary arterial pressure during rest and exercise in healthy subjects A systematic review”
European Resiratory Journal 2009 (prepublished online 26.März 2009)

Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC;
„Measuring FEV(6) for Detecting Early Airway Obstruction in the Primary Care Setting. Quality and Utility of the New PiKo-6 Device”
Respiration 2009 (prepublished online 28.Jänner 2009)

Pirker R, Filipits M;
„Targeted therapies in lung cancer“
Current Pharmaceutical Design 2009; 15(2):188-206

Funk GC, Kirchheiner K, Burghuber OC, Hartl S;
“BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with CO PD – a cross-sectional study”;
Respiratory Research Jänner 2009, 10(1):1

Vonbank K, Funk GC, Marzluf B, Burian B, Ziesche R, Stiebellehner L, Petkov V, Haber P;
„Abnormal pulmonary arterial pressure limits exercise capacity in patients with CO PD”;
Wiener Klinische Wochenschrift Dezember 2008; 120(23-24):749-755

Poelzl G, Zwick RH, Grander W, Metzler B, Jonetzko P, Frick M, Ulmer H, Pachinger O, Roithinger FX;
„Safety and effectiveness of levosimendan in patients with predominant right heart failure”
Herz 2008; 33(5):368-73

Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H;
„Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy”
Lung Cancer Dezember 2008 (prepublished online 8.Dezember)

Petrovic M, Lahrmann H, Pohl W, Wanke T;
„Idiopathic diaphragmatic paralysis-Satisfactory improvement of inspiratory muscle function by inspiratory muscle training“
Respiratory Physiology and Neurobiology Dezember 2008 (prepublished online 7.Dezember 2008)

Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M;
„Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study“
Respiratory Medicine Dezember 2008, 102(12):1833-8

Voswinckel R, Reichenberger F, Gall H, Schmehl T, Gessler T, Schmermuly RT, Grimminger F, Rubin LJ, Seeger W, Ghofrani HA, Olschewski H;
„Metered dose inhaler delivery of treprostinil fort he treatment of pulmonary hypertension“
Pulmonary Pharmacology and Therapeutics November 2008 (prepublished online 30.November 2008)

Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant’anna TJ, Fontana AD, Probst VA, Brunetto AF, Spruit MA, Wouters EF, Burghuber OC, Hart A;
„Comparison of daily physical activity between COPD patients from Central Europe and South America”
Respiratory Medicine 2008 (prepublished online 8.November)

Kovacs G, Reiter G, Reiter U, Rienmüller R, Peacock A, Olschewski H;
„The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension”
Respiration November 2008; 76(4):458-70

Pirker R;
„Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer”
Clinical Advances in Haematology and Oncology Oktober 2008; 6(10):735-6

Lamprecht B, Porsch P, Pirich C, Studnicka M;
„Electromagnetic navigation bronchoscopy in combination with PET-CT and rapid on-site cytopathologic Examination for diagnosis of peripheral lung lesions”
Lung 2008 (prepublished online 5.Oktober 2008) 

Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC;
„Determinants of systemic vascular function in patients with stable COPD”
American Journal of Respiratory and Critical Care Medicine 2008 (prepublished online 3.Oktober 2008)

Desole S, Kähler CM.
"Decompensated pulmonary hypertension"
Deutsche Medizinische Wochenschrift 2008 Oct;133 Suppl 6:S215-8. Epub 2008 Sep 23.

Steiner I, Errhalt P, Kubesch K, Hubner M, Holy M, Bauer M, Muller M, Hinterberger S, Widmann R, Mascher D, Freissmuth M, Kneussl M;
„Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers.”
Naunyn-Schmiedeberg´s Archives of Pharmacology
September 2008, 378(3):323-33

Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Furst DE;
"Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis."
EPOSS-Omeract Group (incl. Kähler CM)
Arthritis Rheumatism 2008 Aug 15;59(8):1202.

Bush A, Eber E;
„The value of FeNO measurement in asthma management: the motion for Yes, it´s No - - or, the wrong end of the Stick!”
Peadiatric Respiratory Reviews Mai 2008; 9(2):127-31

Pirker R, Ramlau RA , Schuette W, Zatloukal P, Ferreira I, Lillie T, Vansteenkiste JF;
„Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide”
Journal of Clinical Oncology Mai 2008; 26(14):2342-9

Gomberg-Maitland M, Olschewski H;
„Prostacyclin therapies for the treatment of pulmonary arterial hypertension” (Review)
European Respiratory Journal April 2008; 31(4):891-901

Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC;
„Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure“
CHEST, prepublished online 13. März 2008

Clement A, Eber E;
„Interstitial lung disease in infants and children”
European Respiratory Journal März 2008; 31(3):658-66. Review

Pircher A, Kähler CM, Skvortsov S, Dlaska M, Kawaguchi G, Schmid T, Gunsilius E, Hilbe W.
"Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance."
Oncology Reports 2008 Feb;19(2):345-52.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC;
„Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease”
Clinical Science Februar 2008

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC;
„Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease”
Clinical Science Februar 2008

Riedler J, Eber E, Frischer T, Götz M, Horak E, Zach M;.
„Leitlinie zur Behandlung des Asthma bronchiale bei Kindern und Jugendlichen”
Wiener Klinische Wochenschrift Februar 2008; 120(1-2):54-60



Die Liste beinhaltet Publikationen ab Jänner 2008, soweit sie uns bekannt
geworden sind. Wir bitten um Information fehlender Arbeiten.